Lannett Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LANNETT, and what generic and branded alternatives to LANNETT drugs are available?
LANNETT has one hundred and thirty-two approved drugs.
There is one tentative approval on LANNETT drugs.
Summary for Lannett
US Patents: | 0 |
Tradenames: | 97 |
Ingredients: | 94 |
NDAs: | 132 |
Patent Litigation for Lannett: | See patent lawsuits for Lannett |
PTAB Cases with Lannett as petitioner: | See PTAB cases with Lannett as petitioner |
Drugs and US Patents for Lannett
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lannett Co Inc | TERBUTALINE SULFATE | terbutaline sulfate | TABLET;ORAL | 077152-002 | Mar 25, 2005 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lannett | BUTALAN | butabarbital sodium | ELIXIR;ORAL | 085880-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Lannett | LANORINAL | aspirin; butalbital; caffeine | TABLET;ORAL | 086986-002 | Oct 18, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Lannett Co Inc | CHLORPROMAZINE HYDROCHLORIDE | chlorpromazine hydrochloride | TABLET;ORAL | 212996-004 | Jan 22, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lannett Co Inc | ESTRADIOL | estradiol | TABLET;ORAL | 040138-003 | Jan 30, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Lannett Co Inc | PAROXETINE HYDROCHLORIDE | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 204744-002 | Jun 10, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lannett | SERPALAN | reserpine | TABLET;ORAL | 010124-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for LANNETT drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.